Evidence map›Paper›PMID 32748281›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2020

[Cardiac rhythm monitoring : New tools on the horizon].

Aenne S von Falkenhausen, Stephanie Fichtner, Stefan Kääb, Moritz F Sinner

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aenne S von FalkenhausenMedizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, München, Deutschland.
Stephanie FichtnerMedizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, München, Deutschland.
Stefan KääbMedizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, München, Deutschland.
Moritz F SinnerMedizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, München, Deutschland. msinner@med.lmu.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac rhythm monitoring plays an integral role in the diagnosis and treatment of various conditions. Technological developments of recent years have partly increased the ease of use and the availability of cardiac rhythm monitoring. Yet, the multitude of options has also added confusion. Various manufacturers offer devices for pulse wave and electrocardiogram analysis. Their use plays an important role in clinical routine, both for diagnostic purposes and for the need to interpret opportunistic findings. This article is intended to provide an overview of existing technologies and to highlight their advantages and disadvantages. It also is intended to introduce future technologies. In any case it is important to emphasize that numerous clinical trials will be required to evaluate the benefit of modern cardiac rhythm monitoring and foster its medical use.

Indexed as

Heart RateAtrial FibrillationElectrocardiographyHumansAtrial fibrillationCardiac arrhythmiasCardiac rhythmElectrocardiographyWearable electronic devices

Identifiers

PMID32748281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.